Article

Mechanism-based inhibitors of MenE, an acyl-CoA synthetase involved in bacterial menaquinone biosynthesis

Molecular Pharmacology & Chemistry Program and Tri-Institutional Research Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 422, New York, NY 10065, USA.
Bioorganic & medicinal chemistry letters (Impact Factor: 2.65). 09/2008; 18(22):5963-6. DOI: 10.1016/j.bmcl.2008.07.130
Source: PubMed

ABSTRACT Menaquinone (vitamin K(2)) is an essential component of the electron transfer chain in many pathogens, including Mycobacterium tuberculosis and Staphylococcus aureus, and menaquinone biosynthesis is a potential target for antibiotic drug discovery. We report herein a series of mechanism-based inhibitors of MenE, an acyl-CoA synthetase that catalyzes adenylation and thioesterification of o-succinylbenzoic acid (OSB) during menaquinone biosynthesis. The most potent compound inhibits MenE with an IC(50) value of 5.7microM.

0 Bookmarks
 · 
95 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tuberculosis (TB) and HIV co-infections place an immense burden on health care systems and pose particular diagnostic and therapeutic challenges. With the emergence of multidrug resistant and extensively drug resistant strains of Mycobacterium tuberculosis, the conditions have detoriated much more. Thus there exists a huge urge for the development of novel lead molecules against these infections. In this regard, we tried to analyse the phytochemicals from distinct sources for their anti-tuberculosis and anti-HIV activity. It is also important to mention that along with new lead compounds, the search for new drug targets continues. Recently, enzymes involved in menaquinone biosynthesis have been used as drug targets. As the structures of proteins involved in menaquinone pathway are absent, they were homology modeled using SWISS MODEL and validated using SAVES server. Our docking results demonstrated that phytochemicals from tea especially Rutin (CID_5280805), Theaflavin (CID_114777), Orientin (CID_5281675) and 8-C-ascorbyl-epigallocatechin (CID_3001587) had high affinity for menB, menC, menD, menE, Chorismate synthase and HIV-1 protease. These ligands were found to be non toxic, non mutagenic and non carcinogenic. However, further experimental and clinical verifications are needed to establish the estimated potential of these ligands as anti-tuberculosis and anti-HIV agents via inhibition of menaquinone biosynthesis
    WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES 02/2014; 3(2):1924-1936. · 2.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: 1,4-Dihydroxy-2-naphthoyl coenzyme A (DHNA-CoA) synthase catalyzes an essential intramolecular Claisen condensation in menaquinone biosynthesis and is an important target for the development of new antibiotics. This enzyme in Mycobacterium tuberculosis is cofactor-free and is classified as a type II DHNA-CoA synthase, differing from type I enzymes, which rely on exogenous bicarbonate for catalysis. Its crystal structures in complex with product analogues have been determined at high resolution to reveal ligand-dependent structural changes, which include the ordering of a 27-residue active-site loop (amino acids 107-133) and the reorientation of the carboxy-terminal helix (amino acids 289-301) that forms part of the active site from the opposing subunit across the trimer-trimer interface. These structural changes result in closure of the active site to the bulk solution, which is likely to take place through an induced-fit mechanism, similar to that observed for type I DHNA-CoA synthases. These findings demonstrate that the ligand-dependent conformational changes are a conserved feature of all DHNA-CoA synthases, providing new insights into the catalytic mechanism of this essential tubercular enzyme.
    Acta Crystallographica Section D Biological Crystallography 11/2014; 70(Pt 11):2959-69. DOI:10.1107/S1399004714019440 · 7.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mycobacterium tuberculosis (Mtb) lipids are indelibly imprinted in just about every key aspect of tuberculosis (TB) basic and translational research. Although the interest in these compounds originally stemmed from their abundance, structural diversity, and antigenicity, continued research in this field has been driven by their important contribution to TB pathogenesis and their interest from the perspective of drug, vaccine, diagnostic, and biomarker development. This article summarizes what is known of the roles of lipids in the physiology and pathogenicity of Mtb and the exciting developments that have occurred in recent years in identifying new lead compounds targeting their biogenesis.
    Cold Spring Harbor Perspectives in Medicine 08/2014; 4(10). DOI:10.1101/cshperspect.a021105 · 7.56 Impact Factor

Preview

Download
0 Downloads
Available from